Back to top
more

CONMED (CNMD)

(Delayed Data from NYSE)

$71.16 USD

71.16
319,789

+0.82 (1.17%)

Updated May 10, 2024 04:00 PM ET

After-Market: $71.15 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CNMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 24 29 21 27 26
Receivables 242 191 184 177 189
Notes Receivable 0 0 0 0 0
Inventories 318 332 232 195 165
Other Current Assets 31 29 24 17 18
Total Current Assets 616 581 460 417 397
Net Property & Equipment 121 116 109 111 119
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 11 10 10 7 6
Intangibles 1,456 1,497 1,089 1,120 1,151
Deposits & Other Assets 96 94 99 97 102
Total Assets 2,300 2,298 1,766 1,752 1,775
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 88 73 58 53 56
Current Portion Long-Term Debt 1 70 12 18 14
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 70 55 60 50 54
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 152 99 66 68 65
Total Current Liabilities 311 297 197 190 188
Mortgages 0 0 0 0 0
Deferred Taxes/Income 61 67 69 58 74
Convertible Debt 0 0 0 0 0
Long-Term Debt 973 985 672 735 755
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 121 204 43 59 47
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,466 1,552 981 1,043 1,065
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 447 413 397 383 379
Retained Earnings 453 413 497 457 471
Other Equity -50 -58 -54 -64 -59
Treasury Stock 15 23 54 68 81
Total Shareholder's Equity 834 746 785 709 710
Total Liabilities & Shareholder's Equity 2,300 2,298 1,766 1,752 1,775
Total Common Equity 834 746 785 709 710
Shares Outstanding 30.70 30.40 29.20 28.60 28.30
Book Value Per Share 27.17 24.52 26.90 24.79 25.10

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 34 24 31 28 26
Receivables 241 242 230 229 213
Notes Receivable 0 0 0 0 0
Inventories 322 318 326 327 335
Other Current Assets 38 31 39 31 35
Total Current Assets 636 616 626 616 610
Net Property & Equipment 118 121 120 117 115
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 11 0 0 0
Intangibles 1,448 1,456 1,473 1,481 1,489
Deposits & Other Assets 108 96 107 109 106
Total Assets 2,309 2,300 2,326 2,323 2,320
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 102 88 82 79 77
Current Portion Long-Term Debt 1 1 71 70 70
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 50 70 60 55 49
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 139 152 163 150 125
Total Current Liabilities 291 311 376 353 321
Mortgages 0 0 0 0 0
Deferred Taxes/Income 64 61 67 66 66
Convertible Debt 0 0 0 0 0
Long-Term Debt 990 973 942 971 995
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 109 144 152 186
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,455 1,466 1,529 1,543 1,568
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 458 447 440 433 420
Retained Earnings 466 453 426 416 408
Other Equity -50 -50 -54 -53 -55
Treasury Stock 20 15 15 16 21
Total Shareholder's Equity 855 834 796 780 752
Total Liabilities & Shareholder's Equity 2,309 2,300 2,326 2,323 2,320
Total Common Equity 855 834 796 780 752
Shares Outstanding 30.80 30.70 30.70 30.70 30.50
Book Value Per Share 27.75 27.17 25.94 25.41 24.67